Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
What is the Immune System?01:38

What is the Immune System?

Overview
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
The Skin Microbiota01:27

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.

The Journal of investigative dermatology·2026
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.

Dermatology and therapy·2026
Same author

Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis.

Acta dermato-venereologica·2026
Same author

Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.

The Journal of dermatological treatment·2026
Same author

Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.

American journal of clinical dermatology·2026

Related Experiment Video

Updated: Jun 5, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Innate immunity in atopic dermatitis.

Andreas Wollenberg1, Helen-Caroline Räwer, Jürgen Schauber

  • 1Department of Dermatology and Allergy, Ludwig-Maximilian-University of Munich, Germany. andreas.wollenberg@lrz.uni-muenchen.de

Clinical Reviews in Allergy & Immunology
|December 25, 2010
PubMed
Summary
This summary is machine-generated.

Atopic dermatitis involves skin barrier defects and immune system issues, increasing infection risk. Therapies may boost innate immunity and reduce adaptive immune responses.

Related Experiment Videos

Last Updated: Jun 5, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Area of Science:

  • Immunology
  • Dermatology
  • Genetics

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense itching and skin barrier dysfunction.
  • Genetic factors, such as filaggrin gene mutations, combined with immune system abnormalities, predispose AD patients to skin infections.
  • Defects in the innate immune system contribute to barrier impairment, allergen penetration, and secondary infections in AD.

Purpose of the Study:

  • To elucidate the role of innate and adaptive immunity in the pathogenesis of atopic dermatitis.
  • To understand the mechanisms underlying increased susceptibility to infections in AD patients.
  • To identify potential therapeutic targets for atopic dermatitis.

Main Methods:

  • Review of existing literature on atopic dermatitis, focusing on genetic, immunological, and clinical aspects.
  • Analysis of the function of the innate immune system, including antimicrobial peptides and dendritic cells, in AD.
  • Examination of the association between filaggrin mutations and immune responses in AD.

Main Results:

  • Loss-of-function mutations in the filaggrin gene are linked to AD.
  • Impaired function of antimicrobial peptides (cathelicidin, beta-defensins) and altered dendritic cell populations are observed in AD skin.
  • Eczema herpeticum, a severe viral infection, occurs frequently in AD patients due to specific molecular and cellular defects.

Conclusions:

  • Atopic dermatitis pathogenesis involves a complex interplay of genetic predisposition, skin barrier defects, and immune dysregulation.
  • Innate immune deficiencies, including defective antimicrobial peptide production and altered immune cell function, are critical in AD.
  • Future treatments for AD may involve enhancing innate immune responses alongside modulating adaptive immunity.